CONTACT: Chelsea Wuth, 517-241-2112, [email protected]

MDHHS launches OpiRescue smartphone app to help Michigan residents prevent and reduce opioid overdoses

LANSING, Mich. – In an effort to reduce the occurrence of overdoses and help residents learn to treat an overdose, the Michigan Department of Health and Human Services (MDHHS) is launching OpiRescue, a smartphone app aimed at reducing harm.

The OpiRescue app helps anyone, including first responders, prevent opioid misuse and reduce opioid overdose deaths by addressing education, prevention and tracking of overdose reversals.

“Preventing opioid deaths includes offering a variety of strategies to provide residents tools when and where they need them,” said Dr. Natasha Bagdasarian, MDHHS chief medical executive. “The OpiRescue app will support those who may encounter an overdose to immediately begin life-saving treatment to an affected individual.”

The OpiRescue app provides:

  • Educational content to identify and reverse overdoses.
  • A Naloxone finder to locate the medication nearby.
  • A treatment locator.
  • Information on how to report an overdose reversal.

The OpiRescue app is available statewide in Michigan on both Android and iOS platforms. It is free to use and anonymous. It can be downloaded at Apple iOS app store or through Google Play

MDHHS partners, including Prepaid Inpatient Health Plans and Syringe Service Programs, actively involved in caring for members of the public experiencing opioid use disorder will have access to a dashboard for their region. The dashboard will allow those partners to view overdose reversal data in near real time and allocate additional resources as needed to areas with increased reports of overdose reversals. 

For more information on Naloxone and how to obtain the medication, visit

Questions or comments for the Safe Opioid Task Force

The MOA established the Safe Opioid Task Force in 2015. The Task Force works to advocate on behalf of physicians and the patients they serve on the issues of preventing addiction, treating addiction, and providing information on safe prescribing guidelines.

Questions or Comments
If you have questions, comments or concerns regarding the information being shared, please use this form. Your submission will be forwarded to members of the Task Force. The time is takes to reply may  depend on the issue. 

Safe Opioid Task Force Question/Comment form

Proposed CDC Clinical Practice Guideline for Prescribing Opioids - Public Comments are being accepted

Proposed CDC Clinical Practice Guideline for Prescribing Opioids–United States, 2022 that can be found in the following URL within the Federal Register - Federal Register :: Proposed 2022 CDC Clinical Practice Guideline for Prescribing Opioids. This update provides key revisions from the 2016 version, particularly for those who have chronic disease that incites severe intractable and largely incurable pain. 

Prescribing Opioids—United States, 2022 (the clinical practice guideline). The clinical practice guideline updates and expands the CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016, and provides evidence-based recommendations for clinicians who provide pain care, including those prescribing opioids, for outpatients age 18 years and older with acute pain (duration less than 1 month), subacute pain (duration of 1-3 months), or chronic pain (duration of 3 months or more), not including sickle cell disease-related pain management, cancer pain treatment, palliative care, and end-of-life care. The clinical practice guideline includes recommendations for primary care clinicians (including physicians, nurse practitioners, and physician assistants) as well as for outpatient clinicians in other specialties (including those managing dental and post-surgical pain in outpatient settings and emergency clinicians providing pain management for patients being discharged from emergency departments). This voluntary clinical practice guideline provides recommendations and does not require mandatory compliance; and the clinical practice guideline is intended to be flexible so as to support, not supplant, clinical judgment and individualized, patient-centered decision-making.

CDC Clinical Practice Guideline for Prescribing Opioids
2016 vs. 2022 CDC Opioid Guideline comparison (PDF) from the U.S. Pain Foundation

 5 Strategic Pillars to Combat opioid abuse

The Michigan Osteopathic Association (MOA) has developed a strategy for combating the opioid crisis facing Michigan. The MOA's "5 Strategic Pillars" were developed based on recommendations from the MOA Presidential Task Force on Safe Opioid Use, the Michigan Governor's Task Force and The Office of the White House.

On this page, you will find news and info about efforts from the MOA and around Michigan to lessen the burden of the opioid epidemic, a full cadre of resources and useful links for both providers and patients and a section on the MOA Presidential Task Force on Safe Opioid Use.

Goal - reduce opioid-related deaths and morbidity, while we treat patients with pain and/or addiction with compassion and expertise.
Click here for the 5 Strategic Pillars


There are many online resources available to learn more about the opioids issue in Michigan. The MOA has compiled some web links for you.

Safe Drug Disposal Information for Michigan

Providers' Clinical Support System For Opioid Therapies

Balancing Pain Management and Prescription Opioid Abuse

Opioid painkiller prescribing varies widely among states

Prescription Painkiller Overdoses

Prescription Painkiller Overdoses in the US

Gov. Rick Snyder forms task force to address prescription drug and opioid problems in Michigan

MAPS Report 2014- (PDF)

America's Addiction to Opioids: Heroin and Prescription Drug Abuse

Prescription Opioid and Heroin Abuse 

Incidence of Neonatal Abstinence Syndrome — 28 States